Neuronetics (STIM) Short Interest Ratio & Short Volume → get a piece of the profit from this land (From True Market Insiders) (Ad) Free STIM Stock Alerts $2.61 +0.09 (+3.57%) (As of 05/17/2024 ET) Add Compare Share Share Short InterestStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial MediaStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial Media Neuronetics Short Interest DataCurrent Short Volume58,300 sharesPrevious Short Volume57,700 sharesChange Vs. Previous Month+1.04%Dollar Volume Sold Short$196,471.00Short Interest Ratio / Days to Cover0.3Last Record DateApril 30, 2024Outstanding Shares30,000,000 sharesPercentage of Shares Shorted0.19%Today's Trading Volume207,326 sharesAverage Trading Volume151,348 sharesToday's Volume Vs. Average137% Short Selling Neuronetics ? Sign up to receive the latest short interest report for Neuronetics and its competitors with MarketBeat's FREE newsletter. Email Address Skip Charts & View Short Interest HistoryShort InterestDays to CoverShort Percent of FloatSTIM Short Interest Over TimeSTIM Days to Cover Over TimeSTIM Percentage of Float Shorted Over Time Ad True Market Insidersget a piece of the profit from this land This isn’t the prettiest land on earth. But it might be the most valuable. And you don’t have to own, lease, or rent any land.Click here to see my #1 investment for 2024. Neuronetics Short Interest History Export to ExcelReport DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date 4/30/202458,300 shares $196,471.00 +1.0%N/A0.3 $3.37 4/15/202457,700 shares $240,032.00 -39.0%N/A0.3 $4.16 3/31/202494,600 shares $450,296.00 +77.8%N/A0.5 $4.76 3/15/202453,200 shares $207,480.00 -64.9%N/A0.3 $3.90 2/29/2024151,700 shares $455,100.00 +21.7%N/A0.7 $3.00 2/15/2024124,700 shares $392,805.00 -61.0%0.5%0.6 $3.15 Get the Latest News and Ratings for STIM and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Neuronetics and its competitors with MarketBeat's FREE daily newsletter. 1/31/2024319,700 shares $1.09 million +7.0%N/A1.8 $3.40 1/15/2024298,900 shares $908,656.00 -21.4%N/A1.8 $3.04 12/31/2023380,100 shares $1.10 million -2.7%N/A2.6 $2.90 12/15/2023390,700 shares $840,005.00 +12.4%N/A3.1 $2.15 11/30/2023347,700 shares $632,814.00 -5.3%N/A4.1 $1.82 11/15/2023367,000 shares $499,120.00 +0.9%N/A4.8 $1.36 10/31/2023363,800 shares $418,370.00 +4.8%N/A3.6 $1.15 10/15/2023347,000 shares $388,640.00 -9.5%N/A2.9 $1.12 9/30/2023383,200 shares $517,320.00 -11.2%N/A2.8 $1.35 9/15/2023431,600 shares $617,188.00 -6.1%N/A3.2 $1.43 8/31/2023459,700 shares $753,908.00 +8.0%N/A3.3 $1.64 8/15/2023425,600 shares $766,080.00 -5.4%N/A3.1 $1.80 7/31/2023450,000 shares $886,500.00 +3.6%1.8%3 $1.97 7/15/2023434,200 shares $885,768.00 -11.1%1.7%2.8 $2.04 6/30/2023488,200 shares $1.05 million +9.2%1.9%3.3 $2.15 6/15/2023447,200 shares $1.05 million +31.8%1.8%2.7 $2.34 5/31/2023339,200 shares $926,016.00 +11.5%1.3%1.6 $2.73 5/15/2023304,200 shares $857,844.00 -19.8%1.2%1.2 $2.82 4/30/2023379,400 shares $868,826.00 -4.0%1.5%1.4 $2.29 4/15/2023395,300 shares $877,566.00 +0.2%1.5%1.6 $2.22 3/31/2023394,500 shares $1.15 million +53.7%1.5%1.5 $2.91 3/15/2023256,700 shares $785,502.00 +23.6%1.0%1 $3.06 2/28/2023207,700 shares $1.18 million +1.4%0.8%0.9 $5.69 2/15/2023204,800 shares $1.21 million -8.6%0.8%0.9 $5.93 1/31/2023224,000 shares $1.32 million -17.1%0.9%1 $5.88 1/15/2023270,200 shares $1.69 million -13.6%1.1%1.2 $6.27 12/30/2022312,800 shares $2.15 million -28.4%1.3%1.5 $6.87 12/15/2022436,700 shares $2.90 million +120.3%1.8%2.2 $6.63 11/30/2022198,200 shares $1.24 million +18.8%0.8%1.1 $6.28 11/15/2022166,800 shares $817,320.00 -43.3%0.7%1.1 $4.90 10/31/2022294,200 shares $979,686.00 -11.8%1.2%2.5 $3.33 10/15/2022333,700 shares $917,675.00 -11.9%1.4%2.3 $2.75 9/30/2022378,900 shares $1.20 million -18.0%1.6%0.6 $3.18 9/15/2022461,900 shares $1.36 million +19.9%1.9%0.7 $2.94get a piece of the profit from this land (Ad)This isn’t the prettiest land on earth. But it might be the most valuable. And you don’t have to own, lease, or rent any land.Click here to see my #1 investment for 2024. STIM Short Interest - Frequently Asked Questions What is Neuronetics' current short interest? Short interest is the volume of Neuronetics shares that have been sold short but have not yet been closed out or covered. As of April 30th, investors have sold 58,300 shares of STIM short. Learn More on Neuronetics' current short interest. Is Neuronetics' short interest increasing or decreasing? Neuronetics saw a increase in short interest in April. As of April 30th, there was short interest totaling 58,300 shares, an increase of 1.0% from the previous total of 57,700 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment. How does Neuronetics' short interest compare to its competitors? Here is how the short interest of companies in the industry of "surgical & medical instruments" compare to Neuronetics: Pro-Dex, Inc. (0.72%), enVVeno Medical Corporation (6.81%), Monogram Orthopaedics, Inc. (1.64%), SEP Acquisition Corp. (0.59%), Sensus Healthcare, Inc. (0.24%), BrainsWay Ltd. (0.39%), DarioHealth Corp. (4.55%), IceCure Medical Ltd (1.39%), Apyx Medical Co. (1.90%), Allurion Technologies Inc. (1.45%), Which stocks are the most shorted right now? As of the most recent reporting period, the following stocks had the largest short interest positions: T-Mobile US, Inc. ($3.98 billion), Occidental Petroleum Co. ($3.35 billion), Charter Communications, Inc. ($3.06 billion), General Motors ($2.88 billion), Moderna, Inc. ($2.32 billion), Tractor Supply ($2.27 billion), Royal Caribbean Cruises Ltd. ($2.22 billion), Coinbase Global, Inc. ($2.18 billion), Williams-Sonoma, Inc. ($1.95 billion), and Chesapeake Energy Co. ($1.52 billion). View all of the most shorted stocks. What does it mean to sell short Neuronetics stock? Short selling STIM is an investing strategy that aims to generate trading profit from Neuronetics as its price is falling. STIM shares are trading up $0.09 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit. How does a short squeeze work against Neuronetics? A short squeeze for Neuronetics occurs when it has a large amount of short interest and its stock appreciates in price. This forces short sellers to cover their short interest positions by buying actual shares of STIM, which in turn drives the price of the stock up even further. How often is Neuronetics' short interest reported? Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including STIM, twice per month. The most recent reporting period available is April, 30 2024. More Short Interest Resources from MarketBeat Related Companies: Pro-Dex Short Interest Data enVVeno Medical Short Interest Data Monogram Orthopaedics Short Interest Data SEP Acquisition Short Interest Data Sensus Healthcare Short Interest Data BrainsWay Short Interest Data DarioHealth Short Interest Data IceCure Medical Short Interest Data Apyx Medical Short Interest Data Allurion Technologies Short Interest Data Short Interest Tools: Stocks to Short Largest Short Interest Positions Short Interest Increases Short Interest Decreases Short Interest Reporting Dates This page (NASDAQ:STIM) was last updated on 5/18/2024 by MarketBeat.com Staff From Our PartnersObama’s Forever Term [exposed]Porter & CompanyCEO of Biggest AI Chipmaker Just Dropped a Bombshell…Banyan Hill PublishingElon’s New Device is About to Shock the WorldInvestorPlaceThe Overlooked Retirement Asset You Probably Don’t OwnCrypto 101 MediaMissed NVDA? Buy this AI stock NOWChaikin AnalyticsUrgent Nvidia WarningAltimetryForget Bitcoin. Crypto Millionaire Predicts 8,788% Gains For THISParadigm Press[URGENT] DO NOT Touch These AI Stocks!Weiss Ratings